The Meakins-Christie Laboratories is one of the premier centres for pulmonary research in the world and Canada. The Meakins was founded in 1972 by Dr. Peter Macklem. It comprises the largest group of investigators within the Translational Research in Respiratory Diseases Program at the RI-MUHC. Our overall mission is to better understand the pathobiology of respiratory disorders. Our goal is to drive innovations in respiratory disease prevention, diagnosis, and therapy. As a result, our research is focused around five main themes: chronic airways disease, lung injury and infection, neuromuscular dysfunction in respiratory diseases, sleep-disordered breathing, and lung cancer.
In the News
2020-2021 Dr. Margaret Becklake Fellowship
Dr. Mikashmi Kohli is the recipient of the inaugural Dr. Margaret Becklake Fellowship in Respiratory Research.
Rifampin for Latent TB: A Better Choice
Dr. Menzies’ study found that 4-months of rifampin is a better course of treatment and more cost-effective for latent TB.
‘Contain COVID-19’ – in its earliest phases
A new clinical trial, designed by Drs. Ezer, Martin, Benedetti & Smith, will test ciclesonide in the early stages of COVID-19.
COVID-19 and COPD
Dr. Jean Bourbeau receives funding from the CIHR COVID-19 Rapid Research Funding Opportunity.
Dysanapsis and COPD risk
Publication by Dr. Benjamin Smith in JAMA highlights a new risk factor for COPD related to lung development
Spring 2020 Awards
Congratulations to the recipients of the Spring 2020 student awards! We wish you much success in your research endeavors.
Upcoming Events
Clinical Aspects of COVID-19 Recovery – Register Now!
Dr. Basil Petrof will be a panelist on the ATS webinar “Clinical Aspects of COVID-19 Recovery”.
CHEST® Journal Club Webinar May 14
Moderated by Dr. Anne Gonzalez of the RECRU and an Associate member of the Meakins-Christie Laboratories
ATS webinar: Genomics of SARS-CoV-2
ATS webinar April 29 on Genomics of SARS-CoV-2, with Dr. Dara Torgerson as moderator.